Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Stem Neoplasms | 10 | 2020 | 204 | 1.540 |
Why?
|
| Glioma | 13 | 2024 | 3401 | 0.820 |
Why?
|
| Brain Neoplasms | 13 | 2024 | 8863 | 0.740 |
Why?
|
| Neurofibromatosis 1 | 1 | 2022 | 569 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2023 | 35421 | 0.510 |
Why?
|
| Anorexia Nervosa | 3 | 2018 | 1286 | 0.460 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 745 | 0.420 |
Why?
|
| Bone Marrow | 6 | 2022 | 2948 | 0.300 |
Why?
|
| Benzimidazoles | 2 | 2022 | 850 | 0.270 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2017 | 2016 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2020 | 3327 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2022 | 2737 | 0.250 |
Why?
|
| Temporal Muscle | 1 | 2023 | 37 | 0.230 |
Why?
|
| Contrast Media | 2 | 2016 | 5300 | 0.230 |
Why?
|
| Growth Charts | 1 | 2023 | 61 | 0.230 |
Why?
|
| Knee | 2 | 2017 | 274 | 0.210 |
Why?
|
| Child | 29 | 2024 | 77709 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 8949 | 0.200 |
Why?
|
| Transposition of Great Vessels | 2 | 2014 | 588 | 0.170 |
Why?
|
| Adolescent | 25 | 2022 | 85781 | 0.170 |
Why?
|
| Perfusion Imaging | 1 | 2020 | 195 | 0.160 |
Why?
|
| Permeability | 2 | 2018 | 738 | 0.160 |
Why?
|
| Levonorgestrel | 1 | 2018 | 77 | 0.150 |
Why?
|
| Ethinyl Estradiol | 1 | 2018 | 116 | 0.150 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 252 | 0.150 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2018 | 275 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11524 | 0.140 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2024 | 2043 | 0.130 |
Why?
|
| Bone Density | 3 | 2022 | 3468 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2017 | 3760 | 0.120 |
Why?
|
| Adiposity | 2 | 2022 | 1807 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2018 | 587 | 0.110 |
Why?
|
| Benchmarking | 1 | 2020 | 1042 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2018 | 683 | 0.110 |
Why?
|
| Quinazolines | 3 | 2015 | 1356 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2018 | 3913 | 0.110 |
Why?
|
| Radiopharmaceuticals | 2 | 2014 | 2645 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2024 | 77449 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2018 | 1959 | 0.110 |
Why?
|
| Absorptiometry, Photon | 3 | 2022 | 1725 | 0.100 |
Why?
|
| Child, Preschool | 13 | 2020 | 41006 | 0.100 |
Why?
|
| Positron-Emission Tomography | 5 | 2017 | 6234 | 0.100 |
Why?
|
| Female | 32 | 2024 | 380194 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2015 | 9239 | 0.100 |
Why?
|
| Water | 3 | 2022 | 1395 | 0.090 |
Why?
|
| Male | 32 | 2024 | 350118 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 238 | 0.090 |
Why?
|
| Research Report | 1 | 2013 | 355 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.090 |
Why?
|
| ROC Curve | 1 | 2018 | 3527 | 0.090 |
Why?
|
| Humans | 42 | 2024 | 744343 | 0.090 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2009 | 9 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 2022 | 3279 | 0.090 |
Why?
|
| Phantoms, Imaging | 3 | 2014 | 2480 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2022 | 2303 | 0.090 |
Why?
|
| Ependymoma | 1 | 2012 | 334 | 0.090 |
Why?
|
| Weight-Bearing | 1 | 2011 | 515 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 868 | 0.080 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2009 | 53 | 0.080 |
Why?
|
| Knee Prosthesis | 1 | 2011 | 425 | 0.080 |
Why?
|
| Diffusion | 4 | 2017 | 833 | 0.080 |
Why?
|
| Disease Progression | 3 | 2020 | 13284 | 0.070 |
Why?
|
| Prognosis | 5 | 2020 | 29063 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
| Algorithms | 3 | 2020 | 13881 | 0.070 |
Why?
|
| Disease-Free Survival | 5 | 2017 | 6895 | 0.070 |
Why?
|
| Brain Stem | 1 | 2010 | 846 | 0.060 |
Why?
|
| Infant | 7 | 2018 | 35136 | 0.060 |
Why?
|
| Camptothecin | 3 | 2013 | 576 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3589 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 1848 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12026 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 14722 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 1442 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2009 | 1285 | 0.060 |
Why?
|
| Infant Behavior | 1 | 2004 | 156 | 0.060 |
Why?
|
| Knee Joint | 1 | 2011 | 1680 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 1677 | 0.050 |
Why?
|
| Histones | 2 | 2023 | 2599 | 0.050 |
Why?
|
| Thalidomide | 1 | 2006 | 890 | 0.050 |
Why?
|
| Femur Head | 1 | 2003 | 301 | 0.050 |
Why?
|
| Brain | 6 | 2005 | 26385 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2001 | 346 | 0.040 |
Why?
|
| Fingers | 1 | 2003 | 513 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2023 | 596 | 0.040 |
Why?
|
| Image Enhancement | 3 | 2005 | 2921 | 0.040 |
Why?
|
| Anisotropy | 2 | 2014 | 1265 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 5535 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2014 | 2305 | 0.040 |
Why?
|
| Pons | 1 | 2019 | 245 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 3537 | 0.040 |
Why?
|
| Quinolones | 2 | 2011 | 367 | 0.040 |
Why?
|
| Cognition | 1 | 2014 | 6770 | 0.040 |
Why?
|
| Brain Edema | 1 | 2001 | 617 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2038 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1205 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1889 | 0.030 |
Why?
|
| Movement | 1 | 2003 | 1471 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 1488 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2003 | 986 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 19905 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 397 | 0.030 |
Why?
|
| Moyamoya Disease | 1 | 1997 | 238 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2004 | 2044 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15076 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 2022 | 25625 | 0.030 |
Why?
|
| Ischemia | 1 | 2003 | 1907 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5078 | 0.030 |
Why?
|
| Ice | 1 | 2014 | 104 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 783 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 2731 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6538 | 0.030 |
Why?
|
| Survival Rate | 3 | 2013 | 12788 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2011 | 8642 | 0.030 |
Why?
|
| Child Development | 1 | 2004 | 2223 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2001 | 1563 | 0.030 |
Why?
|
| Goats | 1 | 2011 | 171 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4186 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2006 | 3481 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3305 | 0.020 |
Why?
|
| Age Factors | 3 | 2017 | 18370 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 7023 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8324 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2031 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2373 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6669 | 0.020 |
Why?
|
| Osteolysis | 1 | 2010 | 270 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2010 | 629 | 0.020 |
Why?
|
| Young Adult | 4 | 2017 | 56430 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 546 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 6993 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 29786 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2019 | 63114 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2012 | 1275 | 0.020 |
Why?
|
| Executive Function | 1 | 2014 | 1364 | 0.020 |
Why?
|
| Tibia | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Time Factors | 3 | 2015 | 40075 | 0.020 |
Why?
|
| Femur | 1 | 2011 | 1297 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 380 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 957 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 2879 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2004 | 379 | 0.010 |
Why?
|
| Adult | 9 | 2014 | 214055 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 21746 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2010 | 1533 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 780 | 0.010 |
Why?
|
| Infant Care | 1 | 2004 | 183 | 0.010 |
Why?
|
| Intensive Care, Neonatal | 1 | 2004 | 198 | 0.010 |
Why?
|
| Epiphyses | 1 | 2003 | 189 | 0.010 |
Why?
|
| Internal Capsule | 1 | 2001 | 113 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 2618 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1590 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9313 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11366 | 0.010 |
Why?
|
| HIV Infections | 1 | 2004 | 16718 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3508 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 1534 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12354 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 53288 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6365 | 0.010 |
Why?
|
| Choline | 1 | 1997 | 493 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 5987 | 0.010 |
Why?
|
| Creatine | 1 | 1997 | 421 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1997 | 576 | 0.010 |
Why?
|
| Learning | 1 | 2004 | 1713 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1997 | 836 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 4982 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 5917 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1107 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39050 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2007 | 3309 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2004 | 6150 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13695 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1997 | 4199 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 72290 | 0.000 |
Why?
|
| Animals | 2 | 2011 | 168757 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5708 | 0.000 |
Why?
|
| United States | 1 | 2007 | 69872 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_